SK Biopharmaceuticals Company Profile

SK Biopharmaceuticals, a research and development company specializing in the discovery of small molecule drug candidates and their development from drug target through commercialization will remain in their headquarters in Fairfield, New Jersey. SK Energy & Chemicals, which manufactures and develops fine chemicals, pharmaceutical intermediates, and API's, will remain in their Fair Lawn, New Jersey offices. SK USA is the US headquarters for SK Group, Korea's third largest conglomerate. SK USA develops new business opportunities in the United States through investment activities and provides business support for existing U.S.-based SK companies.
Location
140 A New Dutch Lane
Fairfield
NJ
07004
United States of America
Contact
Phone: 973)227-3939
Fax: 973)227-4488
Email: dihan@skcorp.com
News Articles
Editorial: Biopharmaceuticals – discovery, development and manufacturing
This Special issue, Biopharmaceuticals – discovery, development and manufacturing is edited by Alois Jungbauer and Klaus Graumann and includes articles on various aspects of the development of bioph...
SMi is proud to present their inaugural conference on Lyophilisation: Freeze-drying in pharmaceuticals & Biopharmaceuticals held on the 25-26 February in London. This conference will provide the perfe...
Kythera Biopharmaceuticals raises $70.4 million in IPO
Kythera Biopharmaceuticals Inc. has raised about $70.4 million in its initial public offering of 4.4 million shares. The Calabasas, Calif., company, which is developing an injectable treatment for dou...
New data from KYTHERA Biopharmaceuticals’ ATX-101 studies on double chin
KYTHERA Biopharmaceuticals, Inc. today announced four abstracts will be presented at the 71st American Academy of Dermatology (AAD) Annual Meeting in Miami Beach, Fla.
Inspiration Biopharmaceuticals and Ipsen Announces New Global Commercialization Agreements
Inspiration Biopharmaceuticals Inc. has announced new license, development and commercialization agreements with its strategic partner, Ipsen.
XTL Biopharmaceuticals buys Proteologics shares
XTL Biopharmaceuticals has acquired 4,620,356 shares of Proteologics from Teva Pharmaceutical for nearly NIS6.5m($1.6m).
NGM Biopharmaceuticals has signed a worldwide agreement with Janssen Pharmaceuticals to discover and develop novel therapeutics for the potential treatment of Type 2 diabetes and other metabolic disea...
Baxter, Ipsen and Inspiration Biopharmaceuticals in a pact for OBI-1
Ipsen and Inspiration Biopharmaceuticals have entered into an Asset Purchase Agreement whereby Baxter International agrees to acquire the worldwide rights to OBI-1, a recombinant porcine factor VIII i...
Drugs and Medications
These highlights do not include all the information needed to use EVITHROM safely and effectively. See full prescribing information for EVITHROM.EVITHROM, Thrombin, Topical (Human)For Topical Use Only...
PubMed Articles
The cost-effectiveness of biopharmaceuticals: A look at the evidence.
Due to the increasing availability and costs of biopharmaceuticals, policymakers are questioning whether they provide good value relative to other health interventions and many are increasingly relyin...
BACKGROUND: The nature of adverse drug reactions observed post-authorization for biopharmaceuticals differs from that observed for chemically synthesized, small molecules (SMs). However, it remains un...
Separation science is the key to successful biopharmaceuticals.
The impact of economic change, advances in science, therapy and production processes resulted in considerable growth in the area of biopharmaceuticals. Progress in selection of microorganisms and impr...
Process validation in manufacturing of biopharmaceuticals. Third edition.
Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars.
Biologics such as monoclonal antibodies are much more complex than small-molecule drugs, which raises challenging questions for the development and regulatory evaluation of follow-on versions of such...
Clinical Trials
Nicotine Vaccination and Nicotinic Receptor Occupancy
This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...
Companies
Itero Biopharmaceuticals, Inc.
Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical an...
Bechtel Group Biopharmaceuticals Production
Design, construction, and validation of facilities for production of human biopharmaceuticals utilizing either fermentation or cell culture, facilities maintenance & operation for the virtual organiza...
BioRexis Pharmaceutical Corporation
BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercializat...
Keryx Biopharmaceuticals Incorporated is a drug discovery and development company, that applies KinAce, its proprietary rational drug discovery technology, to genomics data in order to build a rich pi...
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals is dedicated exclusively to developing treatments for hemophilia, with a primary mission to broaden access to care, including prophylactic therapy, and improve the treat...
More Information about "SK Biopharmaceuticals" on BioPortfolio
We have published hundreds of SK Biopharmaceuticals news stories on BioPortfolio along with dozens of SK Biopharmaceuticals Clinical Trials and PubMed Articles about SK Biopharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SK Biopharmaceuticals Companies in our database. You can also find out about relevant SK Biopharmaceuticals Drugs and Medications on this site too.